MedTrace Logo

International Severe Asthma Registry: Canadian Cohort

NCT04045587 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 714

Last updated 2026-05-01

No results posted yet for this study

Summary

The International Severe Asthma Registry is a global initiative looking to ensure that the care of people with severe asthma will continue to improve by collecting detailed information about the health and treatment of as many people with the disease as possible. The study will gather anonymized longitudinal real-life data for participants with severe asthma for five years. The purpose of the registry is to track the progress of participants and determine how well they are responding to treatment. Medical research using data from the registry will give the investigators a better understanding of severe asthma and help the investigators develop and improve the care and treatment for severe asthma participants. The Canadian cohort of the registry will collect information from Canadian participants with severe asthma across seven different sites.

Conditions

Sponsors & Collaborators

  • University of Alberta

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Laval University

    collaborator OTHER

  • McGill University

    collaborator OTHER

  • Université de Sherbrooke

    collaborator OTHER

  • The Ottawa Hospital

    collaborator OTHER

  • Kingston Health Sciences Centre

    collaborator OTHER

  • University of Saskatchewan

    collaborator OTHER

  • Western University, Canada

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Celine Bergeron · University of British Columbia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-06
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04045587 on ClinicalTrials.gov